Monlunabant in adults with obesity and metabolic syndrome: Open-label extension of a phase 2a trial. Article uri icon

Overview

publication date

  • March 24, 2026

Identity

PubMed Central ID

  • PMC13071180

Scopus Document Identifier

  • 105033891092

Digital Object Identifier (DOI)

  • 10.1111/dom.70580

PubMed ID

  • 41877358

Additional Document Info

volume

  • 28

issue

  • 5